Quidel | QDEL - Cost Of Sales


Quidel reported $-79.5M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Agilent USD 845M 7M Mar/2026
Avanos Medical USD 88M 6.9M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Bruker USD 443.6M 84.4M Mar/2026
Cerus USD 23.42M 3.61M Dec/2024
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Danaher USD 2.36B 512M Mar/2026
Haemonetics USD 136.58M 4.01M Dec/2025
Illumina USD 370M 30M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Merit Medical Systems USD 197.08M 1.5M Mar/2026
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Myriad Genetics USD 63M 1.1M Dec/2025
Neogen USD 112.2M 5.81M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quidel USD -79.5M 528.3M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
STAAR Surgical USD 24.66M 10.6M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Waters USD 725M 350.06M Mar/2026